Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrection
- PMID: 17760692
- DOI: 10.1111/j.1473-2165.2007.00332.x
Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrection
Erratum in
- J Cosmet Dermatol. 2007 Dec;6(4):298
Abstract
Background: Hyaluronic acid is generally accepted today as the "gold standard" filler agent, and its use has subsequently grown enormously. In addition, newer facial volume augmentation indications are constantly evolving. Rare adverse events, such as granulomas, have been described. However, complications are more commonly due to product misplacement or overcorrection leading to unsightly lumps and masses. Hyaluronidase treatment of these latter adverse effects can be both effective and rapid.
Objective: This paper aims to confirm the efficacy of hyaluronidase injections in dissolving unsightly hyaluronic acid overcorrection.
Methods: A case of hyaluronic acid overcorrection is described with evaluation of the effects of hyaluronidase.
Results: The use of hyaluronidase, injected intracutaneously permits the elimination of patient discomfort and inaesthetic lumps within a few hours.
Conclusions: Hyaluronidase is highly effective in eliminating HA volume overcorrection.
Similar articles
-
Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection.J Cosmet Dermatol. 2008 Jun;7(2):136-8. doi: 10.1111/j.1473-2165.2008.00377.x. J Cosmet Dermatol. 2008. PMID: 18482018
-
Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.J Cosmet Dermatol. 2007 Sep;6(3):167-71. doi: 10.1111/j.1473-2165.2007.00331.x. J Cosmet Dermatol. 2007. PMID: 17760694
-
The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.Aesthet Surg J. 2013 Nov 1;33(8):1167-74. doi: 10.1177/1090820X13511970. Epub 2013 Nov 6. Aesthet Surg J. 2013. PMID: 24197934 Review.
-
Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.J Plast Reconstr Aesthet Surg. 2011 Dec;64(12):1590-5. doi: 10.1016/j.bjps.2011.07.013. Epub 2011 Jul 31. J Plast Reconstr Aesthet Surg. 2011. PMID: 21807574
-
Hyaluronic acid fillers.Dermatol Ther. 2006 May-Jun;19(3):141-50. doi: 10.1111/j.1529-8019.2006.00068.x. Dermatol Ther. 2006. PMID: 16784513 Review.
Cited by
-
Multidose Hyaluronidase Administration as an Optimal Procedure to Degrade Resilient Hyaluronic Acid Soft Tissue Fillers.Molecules. 2023 Jan 19;28(3):1003. doi: 10.3390/molecules28031003. Molecules. 2023. PMID: 36770671 Free PMC article.
-
Successful Treatment of Scalp Myxedema with Injected Hyaluronidase: A Case Report.Dermatopathology (Basel). 2020 Feb 7;6(4):260-265. doi: 10.1159/000505354. eCollection 2019 Oct-Dec. Dermatopathology (Basel). 2020. PMID: 32232032 Free PMC article.
-
This month's guideline: The Use of Hyaluronidase in Aesthetic Practice (v2.4).J Clin Aesthet Dermatol. 2018 Jun;11(6):E61-E68. Epub 2018 Jun 1. J Clin Aesthet Dermatol. 2018. PMID: 29942426 Free PMC article. No abstract available.
-
Treatment of the ageing hand with dermal fillers.J Cutan Aesthet Surg. 2012 Jul;5(3):163-9. doi: 10.4103/0974-2077.101369. J Cutan Aesthet Surg. 2012. PMID: 23112510 Free PMC article.
-
Pharmacotherapy for Keloids and Hypertrophic Scars.Int J Mol Sci. 2024 Apr 25;25(9):4674. doi: 10.3390/ijms25094674. Int J Mol Sci. 2024. PMID: 38731893 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical